IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login
Users Online : 484 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


  Download for Citation Managers



SHORT COMMUNICATION

Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
Cure Erkan, Kucuk Adem, Cure Medine Cumhur

Year : 2021 | Volume:  53 | Issue Number:  3 | Page: 226-228



Click here to read this article


Select type of program  for download
EndNote
EndNote format (Mac & Win)
- Download
Reference Manager
Ris format (Win only)
- Download
Procite
Ris format (Win only)
- Download
Medlars Format - Download
RefWorks Format
RefWorks format (Mac & Win)
- Download
BibTex Format
BibTex format (Mac & Win)
- Download
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow